Stay updated on Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-10-03T05:32:13.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, and a notice regarding delays in study record information has been deleted.
    Difference
    1%
    Check dated 2024-09-25T23:09:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    1%
    Check dated 2024-09-18T17:12:09.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-09-11T08:57:00.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The website has been updated to version v2.10.3, with the removal of the 'Helpful Links Provided by Apellis Pharmaceuticals, Inc. Study Website' from the previous version v2.10.2.
    Difference
    0.5%
    Check dated 2024-09-04T06:16:23.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-08-21T01:29:58.000Z thumbnail image

Stay in the know with updates to Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.